Nurix Therapeutics, Inc.
US ˙ NasdaqGM ˙ US67080M1036

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Ponoi Management, LLC. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Ponoi Management, LLC a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:RAPT / RAPT Therapeutics, Inc. 10% Owner 0
US:NGM / NGM Biopharmaceuticals, Inc. 10% Owner 1.000
US:NRIX / Nurix Therapeutics, Inc. 10% Owner 48.406
10% Owner 99.155
US:RVMD / Revolution Medicines, Inc. 10% Owner 2.429.180
US:IMDZ / Immune Design Corp. 10% Owner 0
US:RCUS / Arcus Biosciences, Inc. 10% Owner 0
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Ponoi Management, LLC. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior NRIX / Nurix Therapeutics, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Vânzări din interior NRIX / Nurix Therapeutics, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Achiziții din interior RCUS / Arcus Biosciences, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RCUS / Arcus Biosciences, Inc. Insider Trades
Vânzări din interior RCUS / Arcus Biosciences, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RCUS / Arcus Biosciences, Inc. Insider Trades
Achiziții din interior RVMD / Revolution Medicines, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RVMD / Revolution Medicines, Inc. Insider Trades
Vânzări din interior RVMD / Revolution Medicines, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în NRIX / Nurix Therapeutics, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
2020-11-16 RVMD COLUMN GROUP III, LP 952.023 36,4000 952.023 36,4000 34.653.637 269 23.95 -11.852.686 -34,20
2020-11-16 RVMD COLUMN GROUP III, LP 1.075.133 36,4000 1.075.133 36,4000 39.134.841

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

RVMD / Revolution Medicines, Inc. Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Ponoi Management, LLC, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2024-12-23 2024-12-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1.599.417 0 -100,00
2024-12-23 2024-12-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1.352.008 50.000 -96,43
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
J - Other 1.000 1.000
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -44.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -15.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.298.908 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.298.908 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2.265.758 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -968.990 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -858.035 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -11.103.333 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -90.442 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2.650.177 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -949.862 0 -100,00
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.840 949.862 0,62 0,62 3.627 589.959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.791 944.022 1,81 0,71 11.880 667.896
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176.730 927.231 23,55 5,00 883.403 4.634.857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.542 750.501 1,02 5,00 37.707 3.752.205
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.900 742.959 1,35 5,00 49.494 3.714.349
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733.059 0,07 5,00 2.498 3.662.363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.639 732.559 5,42 5,00 188.105 3.661.037
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.378 694.920 0,78 4,95 26.603 3.437.491
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209.000 689.542 43,49 4,76 994.840 3.282.220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100.070 480.542 26,30 4,84 484.519 2.326.688
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380.472 0,08 4,98 1.493 1.893.495
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.330 380.172 1,15 5,00 21.646 1.900.518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.997 375.842 10,59 5,00 179.942 1.878.759
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.058 339.845 11,50 4,72 165.320 1.602.573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104.090 304.787 51,86 4,99 519.107 1.520.003
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76.877 200.697 62,09 4,86 373.638 975.428
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72.774 123.820 142,57 4,85 353.041 600.676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51.046 51.046 4,75 242.387 242.387
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.477 90.442 56,03 13,50 438.440 1.220.967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951.684 2.650.177 56,03 13,50 12.847.734 35.777.390
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.129 57.965 1,99 13,03 14.715 755.475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.071 1.698.493 1,99 13,03 431.024 22.136.969
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.036 56.836 5,64 13,45 40.834 764.444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88.964 1.665.422 5,64 13,45 1.196.566 22.399.926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.040 53.800 3,94 13,47 27.470 724.460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59.766 1.576.458 3,94 13,47 804.797 21.228.268
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51.760 0,17 13,45 1.197 696.239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.621 1.516.692 0,17 13,45 35.256 20.401.479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51.671 1,31 13,49 9.000 697.223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.534 1.514.071 1,31 13,49 263.582 20.430.117
2022-05-27 2022-05-25 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 63 42.189 0,15 12,45 785 525.460
2022-05-27 2022-05-25 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 1.837 1.236.261 0,15 12,45 22.880 15.397.507
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.429 51.004 2,88 13,43 19.198 685.234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41.863 1.494.537 2,88 13,43 562.425 20.078.955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49.575 1,20 13,37 7.860 662.719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.240 1.452.674 1,20 13,37 230.464 19.419.346
2022-05-25 2022-05-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 538 42.126 1,29 12,00 6.457 505.600
2022-05-25 2022-05-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 15.776 1.234.424 1,29 12,00 189.345 14.815.680
2022-05-25 2022-05-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 338 41.588 0,82 12,50 4.225 519.821
2022-05-25 2022-05-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 9.898 1.218.648 0,82 12,50 123.718 15.232.247
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48.987 1,30 13,48 8.464 660.227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18.406 1.435.434 1,30 13,48 248.069 19.346.205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48.359 1,43 13,25 9.040 640.984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.984 1.417.028 1,43 13,25 264.882 18.782.281
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.067 47.677 4,53 13,20 27.292 629.522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60.583 1.397.044 4,53 13,20 799.932 18.446.429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.939 45.610 6,89 13,42 39.433 611.954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86.110 1.336.461 6,89 13,42 1.155.346 17.931.431
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.094 42.671 2,63 12,90 14.114 550.520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.072 1.250.351 2,63 12,90 413.777 16.131.403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.269 41.577 11,44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125.096 1.218.279 11,44
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37.308 0,05 11,81 201 440.447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1.093.183 0,04 11,81 5.726 12.905.791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.728 37.291 7,89 11,62 31.702 433.362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79.945 1.092.698 7,89 11,62 929.049 12.698.353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34.563 0,26 11,85 1.043 409.478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.564 1.012.753 0,25 11,85 30.376 11.998.389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.657 34.475 8,35 11,23 29.827 387.009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77.866 1.010.189 8,35 11,23 874.108 11.340.180
2022-05-12 2022-05-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 41.250 41.250 10,67 440.199 440.199
2022-05-12 2022-05-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 1.208.750 1.208.750 10,67 12.899.176 12.899.176
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.032 31.818 3,35 11,36 11.727 361.567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.233 932.323 3,35 11,36 343.556 10.594.546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.745 30.786 9,79 10,79 29.627 332.270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80.430 902.090 9,79 10,79 868.073 9.736.167
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.791 28.041 239,89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579.910 821.660 239,88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.250 8.250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241.750 241.750
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -625 6.875 -8,33
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -1.114 1.115 -49,98
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -7.500 15.000 -33,33
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -625 0 -100,00 34,94 -21.840
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 625 625 19,30 12.062 12.062
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.114 0 -100,00 34,96 -38.951
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 1.114 1.114 22,20 24.731 24.731
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.500 0 -100,00 34,48 -258.606
2021-09-29 2021-09-27 4 RAPT RAPT Therapeutics, Inc.
Common Stock
M - Exercise 7.500 7.500 28,27 212.025 212.025
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.720 0 -100,00 37,70 -177.957
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12.939 4.720 -73,27 37,22 -481.634 175.694
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.400 0 -100,00 37,67 -165.762
2021-09-16 2021-09-15 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -11.476 4.400 -72,29 37,21 -427.066 163.741
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.926 0 -100,00 37,31 -109.158
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -32.211 2.926 -91,67 36,85 -1.187.066 107.831
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.496 35.137 -4,08 35,75 -53.477 1.256.028
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -10.807 17.659 -37,96 37,31 -403.261 658.942
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -42.151 28.466 -59,69 36,92 -1.556.046 1.050.851
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.700 70.617 -2,35 35,77 -60.814 2.526.196
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -25.351 15.876 -61,49 37,27 -944.844 591.706
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -29.634 41.227 -41,82 36,79 -1.090.143 1.516.614
2021-09-16 2021-09-14 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.400 70.861 -1,94 35,71 -49.990 2.530.241
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.788 36.633 -11,56 35,28 -168.942 1.292.577
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.726 72.261 -6,14 35,27 -166.692 2.548.739
2021-09-14 2021-09-13 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.803 72.317 -6,23 35,25 -169.309 2.549.218
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.231 41.421 -14,86 35,19 -254.494 1.457.808
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.320 76.987 -8,68 35,19 -257.572 2.708.980
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.187 77.120 -8,52 35,19 -252.940 2.714.169
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 48.652 48.652
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 84.307 84.307
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 84.307 84.307
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 72 163 79,12
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -279.710 0 -100,00
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 279.710 279.710
2021-09-14 2021-09-10 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1.166.666 1.402.008 -45,42
2021-09-03 2021-09-02 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -18.556 0 -100,00 35,43 -657.469
2021-09-03 2021-09-02 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -18.545 0 -100,00 35,43 -657.083
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.064 18.556 -27,57 35,46 -250.484 657.981
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8.805 25.620 -25,58 35,06 -308.681 898.173
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8.976 18.545 -32,62 35,39 -317.674 656.335
2021-09-03 2021-09-01 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -6.904 27.521 -20,06 35,02 -241.753 963.684
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.100 0 -100,00 31,77 -225.532
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -4.318 7.100 -37,82 30,94 -133.602 219.680
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -3.463 34.425 -9,14 31,76 -109.978 1.093.273
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.200 37.888 -5,49 30,79 -67.740 1.166.606
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -3.486 34.425 -9,20 31,76 -110.707 1.093.252
2021-08-24 2021-08-24 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.300 37.911 -5,72 30,81 -70.853 1.167.875
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.100 11.418 -15,53 32,38 -68.005 369.750
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12.354 13.518 -47,75 31,42 -388.123 424.692
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -8.204 25.872 -24,08 30,94 -253.856 800.555
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.007 40.088 -4,77 32,39 -65.012 1.298.555
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -13.623 42.095 -24,45 31,40 -427.810 1.321.930
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.278 55.718 -11,55 30,92 -225.026 1.722.728
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -2.200 40.211 -5,19 32,35 -71.168 1.300.786
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -12.969 42.411 -23,42 31,41 -407.373 1.332.185
2021-08-24 2021-08-23 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -7.605 55.380 -12,07 30,93 -235.198 1.712.721
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.670 34.076 -4,67 30,07 -50.222 1.024.774
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.429 62.996 -2,22 30,08 -42.985 1.894.932
2021-08-24 2021-08-20 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -1.440 62.985 -2,24 30,09 -43.327 1.895.086
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 35.746 35.746
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 64.425 64.425
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 64.425 64.425
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 91 91
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -208.403 0 -100,00
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other 208.403 208.403
2021-08-20 2021-08-18 4 RAPT RAPT Therapeutics, Inc.
Common Stock
J - Other -1.317.005 2.568.674 -33,89
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7.752 48.406 19,07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49.689 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49.689 49.689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1.000.000 989.000 -50,28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30.347 40.654 294,43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111.247 121.554 1.079,33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105.874 116.181 1.027,20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438.338 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438.338 438.338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2.000.000 1.394.333 -58,92
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10.000 99.155 -9,16 36,95 -369.503 3.663.807
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30.107 0 -100,00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30.107 2.584.957 1,18 1,55 46.666 4.006.683
2020-11-18 2020-11-16 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale -1.075.133 2.429.180 -30,68 36,40 -39.134.841 88.422.152
2020-11-18 2020-11-16 4 RVMD Revolution Medicines, Inc.
Common Stock
S - Sale -952.023 2.151.026 -30,68 36,40 -34.653.637 78.297.346
2020-09-23 2020-09-22 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -608.000 3.835.679 -13,68 30,85 -18.756.800 118.330.697
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27.595 1.827.025 1,53 17,67 487.604 32.283.532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.494 1.799.430 2,07 17,64 643.754 31.741.945
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26.135 1.762.936 1,50 17,89 467.555 31.538.925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.359 1.736.801 2,14 17,79 646.827 30.897.690
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1.700.442 0,01 18,00 1.800 30.607.956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11.024 1.700.342 0,65 17,96 197.991 30.538.142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.321 1.689.318 0,44 17,97 131.558 30.357.044
2020-08-19 2020-08-17 4 RAPT RAPT Therapeutics, Inc.
Common Stock
S - Sale -538.654 4.443.679 -10,81 22,75 -12.254.378 101.093.697
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.425 1.681.997 0,38 17,89 114.943 30.090.926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.993 1.675.572 2,32 17,49 664.498 29.305.754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.895 1.637.579 1,23 17,89 355.922 29.296.288
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1.617.684 0,05 17,99 13.169 29.102.135
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.105 1.616.952 0,25 17,99 73.849 29.088.966
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.989.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.836.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.989.000 1.989.000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.836.000 3.394.333 117,82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875.000 1.558.333 128,05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600.000 683.333 720,00
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.834 1.612.847 0,24 17,99 68.974 29.015.118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68.749 1.609.013 4,46 17,93 1.232.670 28.849.603
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1.540.264 0,01 18,00 3.474 27.724.752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24.000 0 -100,00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24.000 44.000 120,00 13,35 320.400 587.400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16.806 16.806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-06-22 2020-06-18 4 RAPT RAPT Therapeutics, Inc.
Stock Option (Right to Buy)
J - Other 22.500 22.500
2020-06-19 2020-06-17 4 RVMD Revolution Medicines, Inc.
Stock Option (Right to Buy)
J - Other 25.318 25.318
2020-06-19 2020-06-17 4 RVMD Revolution Medicines, Inc.
Common Stock
J - Other 7.234 7.234
2020-06-19 2020-02-12 4 RVMD Revolution Medicines, Inc.
Stock Option (Right to Buy)
J - Other 36.168 36.168
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112.602 1.540.071 7,89 14,95 1.683.400 23.024.061
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123.728 1.427.469 9,49 14,38 1.779.209 20.527.004
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.587 1.303.741 1,13 12,41 181.025 16.179.426
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.850 1.289.154 1,17 12,40 184.140 15.985.510
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.274.304 10,21 12,26 1.447.501 15.622.967
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.156.237 11,37 12,53 1.479.380 14.487.650
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.416 1.038.170 0,23 12,49 30.176 12.966.743
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128.377 1.035.754 14,15 12,22 1.568.767 12.656.914
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170.387 907.377 23,12 11,63 1.981.601 10.552.795
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143.082 736.990 24,09 11,77 1.684.075 8.674.372
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148.464 593.908 33,33 11,59 1.720.698 6.883.394
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5.539 6.051.376 0,09 23,15 128.228 140.089.354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36.135 6.045.837 0,60 22,38 808.701 135.305.832
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.307 445.444 1,90 18,00 149.526 8.017.992
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.986 437.137 2,34 17,96 179.349 7.850.981
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38.758 427.151 9,98 17,99 697.256 7.684.446
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.124 388.393 3,77 17,90 252.820 6.952.235
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.800 374.269 11,23 17,91 676.998 6.703.158
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.896 336.469 11,20 17,91 607.077 6.026.160
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.751 302.573 1,26 18,00 67.518 5.446.314
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series C Preferred Stock
C - Conversion -99.758 0 -100,00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series B Preferred Stock
C - Conversion -2.740.043 0 -100,00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Series A Preferred Stock
C - Conversion -5.137.583 0 -100,00
2020-02-18 2020-02-18 4 RVMD Revolution Medicines, Inc.
Common Stock
C - Conversion 7.977.384 7.977.384
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44.900 298.822 17,68 15,96 716.604 4.769.199
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 253.922 0,01 12,00 180 3.047.064
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.409 253.907 3,43 11,99 100.824 3.044.345
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C-2 Preferred Stock
C - Conversion -872.410 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C-2 Preferred Stock
C - Conversion -872.410 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -8.724.100 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -4.362.050 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -7.000.000 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -14.781.963 0 -100,00
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 145.401 145.401
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 145.401 145.401
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 1.454.016 1.454.016
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
P - Purchase 625.000 4.982.333 14,34 12,00 7.500.000 59.787.996
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 727.008 4.357.333 20,03
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 1.166.666 3.630.325 47,36
2019-11-04 2019-11-04 4 RAPT RAPT Therapeutics, Inc.
Common Stock
C - Conversion 2.463.659 2.463.659
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-30 3 RAPT RAPT Therapeutics, Inc.
Common Stock
100.000
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.087 245.498 0,86 11,86 24.752 2.911.606
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.300 243.411 0,95 12,00 27.600 2.920.932
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43.400 241.111 21,95 11,94 518.196 2.878.865
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.721 197.711 21,30 11,29 392.000 2.232.157
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.818 162.990 4,37 10,62 72.407 1.730.954
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 156.172 28,78 10,26 358.074 1.602.325
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.200 121.272 37,70 10,31 342.292 1.250.314
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 88.072 65,64 10,36 361.564 912.426
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 53.172 50,00 10,57 187.343 562.028
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 35.448 100,00 10,50 186.102 372.204
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 17.724 10,26 181.848 181.848
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 80.000 159.155 101,07 8,50 680.000 1.352.818
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 1.331.764 6.009.702 28,47 8,50 11.319.994 51.082.467
2019-08-09 2019-08-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 152 2.597.816 0,01 13,99 2.126 36.343.446
2019-08-09 2019-08-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12 2.597.664 0,00 13,98 168 36.315.343
2019-08-09 2019-08-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 224.500 2.597.652 9,46 14,00 3.143.000 36.367.128
2019-08-07 2019-08-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 310 2.373.152 0,01 13,96 4.328 33.129.202
2019-08-07 2019-08-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.824 2.372.842 0,25 13,98 81.400 33.164.263
2019-08-05 2019-08-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.782 2.367.018 0,08 13,97 24.898 33.072.212
2019-08-05 2019-08-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.600 2.365.236 0,11 13,98 36.346 33.064.107
2019-07-31 2019-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.855 2.362.636 0,38 13,91 123.195 32.870.173
2019-07-31 2019-07-29 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.201 2.353.781 0,82 13,58 260.727 31.961.521
2019-07-26 2019-07-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.059 2.334.580 1,30 13,59 408.634 31.737.214
2019-07-26 2019-07-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.753 2.304.521 1,35 13,37 411.294 30.820.894
2019-07-26 2019-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 29.054 2.273.768 1,29 13,51 392.502 30.717.241
2019-07-23 2019-07-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.760 2.244.714 1,39 13,35 410.535 29.958.851
2019-07-23 2019-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.760 2.213.954 1,41 13,54 416.337 29.965.867
2019-07-23 2019-07-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.222 2.183.194 0,29 13,99 87.043 30.541.792
2019-07-17 2019-07-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.900 2.176.972 0,18 13,86 54.055 30.173.485
2019-07-17 2019-07-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.188 2.173.072 0,75 13,69 221.547 29.740.446
2019-07-15 2019-07-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 21.014 2.156.884 0,98 13,88 291.765 29.946.825
2019-07-15 2019-07-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.870 2.135.870 0,51 13,87 150.752 29.621.527
2019-06-26 2019-06-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.240 2.125.000 0,58 13,78 168.650 29.279.525
2019-06-21 2019-06-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.763 2.112.760 0,18 14,03 52.789 29.638.854
2019-06-21 2019-06-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.400 2.108.997 0,74 13,86 213.385 29.222.684
2019-06-21 2019-06-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.214 2.093.597 0,73 13,91 211.674 29.128.424
2019-06-14 2019-06-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.760 2.078.383 0,52 14,00 150.687 29.106.507
2019-06-14 2019-06-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11.500 2.067.623 0,56 14,13 162.508 29.217.787
2019-06-14 2019-06-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.500 2.056.123 0,37 14,00 104.989 28.782.638
2019-06-11 2019-06-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.900 2.048.623 0,53 13,83 150.718 28.326.925
2019-06-11 2019-06-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.037.723 0,62 13,66 172.176 27.845.077
2019-06-06 2019-06-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.025.123 0,63 13,40 168.884 27.143.736
2019-06-06 2019-06-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.012.523 0,63 13,39 168.764 26.955.733
2019-05-22 2019-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 50.000 1.999.923 2,56 13,50 675.000 26.998.960
2019-05-13 2019-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.923 1.949.923 0,93 13,85 248.234 27.006.434
2019-05-09 2019-05-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 57.000 1.932.000 3,04 14,10 803.700 27.241.200
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -3.400.000 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -2.377.334 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8.408.933 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -12.000.000 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.000 15.000 16,00 240.000 240.000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.875.000 1.875.000 16,00 30.000.000 30.000.000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 13.093.134 13.569.091 2.750,91
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
3.765.000
2019-04-09 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
1.905.000
2019-04-02 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Common Stock
U - Other -6.642.942 0 -100,00 5,85 -38.861.211
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -300.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -20.000.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
C - Conversion -6.502.856 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -444.444 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -3.555.555 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -970.159 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8.333.333 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -11.000.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 79.155 79.155
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 4.666.888 4.677.939 42.230,46
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series C Preferred Stock
C - Conversion -470.427 0 -100,00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series C Preferred Stock
C - Conversion -427.660 0 -100,00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series B Preferred Stock
C - Conversion -875.087 0 -100,00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Series A Preferred Stock
C - Conversion -1.767.676 0 -100,00
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 470.427 470.427
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 427.660 3.070.423 16,18
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 875.087 2.642.763 49,50
2018-03-19 2018-03-19 4 RCUS Arcus Biosciences, Inc.
Common Stock
C - Conversion 1.767.676 1.767.676
2017-10-30 2017-10-27 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 2.681.000 6.642.942 67,67 4,10 10.992.100 27.236.062
2017-10-30 3 IMDZ Immune Design Corp.
Common Stock
5.362.000
2017-10-30 3 IMDZ Immune Design Corp.
Common Stock
5.362.000
2017-10-30 3 IMDZ Immune Design Corp.
Common Stock
5.362.000
2017-10-30 3 IMDZ Immune Design Corp.
Common Stock
5.362.000
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)